[Anal condyloma: its management is still difficult]

Area of Science:

• Dermatology and Venereology
• Oncology
• Infectious Diseases

Context:

• Anal condylomas are a prevalent manifestation of human papillomavirus (HPV) infection, recognized as the most common sexually transmitted disease (STD).
• A significant concern associated with anal condylomas is their potential to progress to anal canal cancer.
• High transmissibility of HPV is noted, with a substantial risk of infection even after a single sexual encounter.

Purpose:

• To review the current understanding of anal condylomas, focusing on their etiology, risks, and management strategies.
• To highlight the challenges in treating anal condylomas due to the lack of specific antiviral therapies.
• To emphasize the importance of established treatment modalities and follow-up protocols.

Summary:

• Anal condylomas stem from human papillomavirus (HPV) infection, a leading STD.
• The primary risk associated with anal condylomas is the development of anal canal cancer.
• Electrocoagulation is currently the preferred treatment method, despite the availability of other therapies like interferon and imiquimod.

Impact:

• Highlights the critical need for effective management of anal condylomas to mitigate cancer risk.
• Underscores the importance of partner treatment and regular patient follow-up for comprehensive care.
• Informs clinical practice regarding the current treatment of choice and the ongoing challenges in HPV management.